Chen Chen, Wang Lin, Zhang Rui, Li Qi, Zhao Ya-Ling, Zhang Guan-Jun, Li Wen-Zhi, Geng Zhi-Min
Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
Department of Geriatric Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
Chronic Dis Transl Med. 2019 Oct 21;5(3):188-196. doi: 10.1016/j.cdtm.2019.08.004. eCollection 2019 Sep.
Most patients with gallbladder cancer (GBC) present with advanced-stage disease and have a poor prognosis. Radical resection remains the only therapeutic option to improve survival in patients with GBC. This study aimed to analyze the prognostic factors in patients with stage Ⅳ GBC and to identify a subgroup of patients who might benefit from R0 resection.
A total of 285 patients with stage Ⅳ GBC were retrospectively analyzed at our institution from January 2008 to December 2012. Factors potentially influencing the prognosis of GBC after surgery were analyzed by univariate and multivariate analyses.
The 1-, 3-, and 5-year overall survival rates were 6.6% (15/229), 0.9% (2/229), and 0 (0/229), respectively. Ascites (relative risk [] = 1.631, 95% confidence interval []: 1.221-2.180, = 0.001), pathological grade ( = 1.337, 95% : 1.050-1.702, = 0.018), T stage ( = 1.421, 95% : 1.099-1.837, = 0.000), M stage ( = 1.896, 95% : 1.409-2.552, = 0.000), and surgery ( = 1.542, 95% : 1.022-2.327, = 0.039) were identified as independent risk factors influencing prognosis. The median survival time (MST) was significantly higher in patients undergoing R0 resection than in those undergoing R1/R2 resection (6.0 . 2.7 months; < 0.001). In subgroup analyses, stage ⅣA patients benefited from R0 resection (MST for R0 . R1/R2, 11.0 . 4.0 months; = 0.003), while R0 resection had a significant survival benefit than R1/R2 resection in patient with stage ⅣB GBC without distant metastasis (MST for R0 . R1/R2, 6.0 . 3.0 months; = 0.007).
Ascites, pathological grade, T stage, M stage, and surgery were independent risk factors influencing prognosis in patients with stage IV GBC. N2 lymph node metastasis did not preclude curative resection, and radical resection should be considered in patients with stage Ⅳ GBC without distant metastasis once R0 margin was achieved.
大多数胆囊癌(GBC)患者就诊时已处于晚期,预后较差。根治性切除术仍然是提高GBC患者生存率的唯一治疗选择。本研究旨在分析Ⅳ期GBC患者的预后因素,并确定可能从R0切除术中获益的患者亚组。
回顾性分析2008年1月至2012年12月在我院就诊的285例Ⅳ期GBC患者。通过单因素和多因素分析潜在影响GBC术后预后的因素。
1年、3年和5年总生存率分别为6.6%(15/229)、0.9%(2/229)和0(0/229)。腹水(相对危险度[RR]=1.631,95%可信区间[CI]:1.221-2.180,P=0.001)、病理分级(RR=1.337,95%CI:1.050-1.702,P=0.018)、T分期(RR=1.421,95%CI:1.099-1.837,P=0.000)、M分期(RR=1.896,95%CI:1.409-2.552,P=0.000)和手术方式(RR=1.542,95%CI:1.022-2.327,P=0.039)被确定为影响预后的独立危险因素。接受R0切除的患者中位生存时间(MST)显著高于接受R1/R2切除的患者(6.0对2.7个月;P<0.001)。亚组分析中,ⅣA期患者从R0切除中获益(R0组与R1/R2组的MST,11.0对4.0个月;P=0.003),而在无远处转移的ⅣB期GBC患者中,R0切除比R1/R2切除有显著的生存获益(R0组与R1/R2组的MST,6.0对3.0个月;P=0.007)。
腹水、病理分级、T分期、M分期和手术方式是影响Ⅳ期GBC患者预后的独立危险因素。N2淋巴结转移并不排除根治性切除,对于无远处转移且切缘达到R0的Ⅳ期GBC患者,应考虑行根治性切除术。